A carregar...
Hepatic Decompensation Likely Attributable to Simeprevir in Patients with Advanced Cirrhosis
BACKGROUND: Hyperbilirubinemia is a common side effect of protease inhibitors used to treat chronic hepatitis C (HCV), and most patients do not experience without clinically overt hepatotoxicity. The safety of second-wave protease inhibitors, including simeprevir, has not been well studied in patien...
Na minha lista:
| Publicado no: | Dig Dis Sci |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6600814/ https://ncbi.nlm.nih.gov/pubmed/25373453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-014-3422-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|